Article
Critical Issues in Diamond-Blackfan Anemia and Prospects for Novel Treatment.
Hematology/oncology clinics of North America - 1 Aug 2018
Li Hojun, Lodish Harvey F, Sieff Colin A
Abstract excerpt
Diamond-Blackfan anemia (DBA) is a severe congenital hypoplastic anemia caused by mutation in a ribosomal protein gene. Major clinical issues concern the optimal management of patients resistant to steroids, the first-line therapy. Hematopoietic stem cell transplantation is indicated in young patients with an HLA-matched unaffected sibling donor, and recent results with matched unrelated donor transplants...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
